Ausgabe 7/2010
Inhalt (33 Artikel)
Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes
J. J. Nolan
Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!
O. Rolandsson, J. P. Palmer
Getting beta all the time: discovery of reliable markers of beta cell mass
J. C. Hutton, H. W. Davidson
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
G. Schernthaner, A. H. Barnett, D. J. Betteridge, R. Carmena, A. Ceriello, B. Charbonnel, M. Hanefeld, R. Lehmann, M. T. Malecki, R. Nesto, V. Pirags, A. Scheen, J. Seufert, A. Sjohölm, A. Tsatsoulis, R. DeFronzo
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
R. A. DeFronzo
Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study
G. Ong, W. A. Davis, T. M. E. Davis
Salt supplementation blunts the blood pressure response to telmisartan with or without hydrochlorothiazide in hypertensive patients with type 2 diabetes
E. I. Ekinci, G. Thomas, R. J. MacIsaac, C. Johnson, C. Houlihan, S. Panagiotopoulos, E. Premaratne, H. Hao, S. Finch, C. O’Callaghan, G. Jerums
Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study
A. M. Arafat, M. Möhlig, M. O. Weickert, C. Schöfl, J. Spranger, A. F. H. Pfeiffer
Evidence that BMI and type 2 diabetes share only a minor fraction of genetic variance: a follow-up study of 23,585 monozygotic and dizygotic twins from the Finnish Twin Cohort Study
M. Lehtovirta, K. H. Pietiläinen, E. Levälahti, K. Heikkilä, L. Groop, K. Silventoinen, M. Koskenvuo, J. Kaprio
Anthropometric measures and glucose levels in a large multi-ethnic cohort of individuals at risk of developing type 2 diabetes
L. de Koning, H. C. Gerstein, J. Bosch, R. Diaz, V. Mohan, G. Dagenais, S. Yusuf, S. S. Anand
Association of glucose metabolism with diastolic function along the diabetic continuum
R. Stahrenberg, F. Edelmann, M. Mende, A. Kockskämper, H. D. Düngen, M. Scherer, M. M. Kochen, L. Binder, C. Herrmann-Lingen, G. Gelbrich, G. Hasenfuß, B. Pieske, R. Wachter
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients
G. Targher, L. Bertolini, M. Chonchol, S. Rodella, G. Zoppini, G. Lippi, L. Zenari, E. Bonora
Variants in ACAD10 are associated with type 2 diabetes, insulin resistance and lipid oxidation in Pima Indians
L. Bian, R. L. Hanson, Y. L. Muller, L. Ma, S. Kobes, W. C. Knowler, C. Bogardus, L. J. Baier
TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion
S. Prudente, R. Baratta, F. Andreozzi, E. Morini, M. G. Farina, A. Nigro, M. Copetti, F. Pellegrini, E. Succurro, L. Di Pietrantonio, C. Brufani, F. Barbetti, B. Dallapiccola, G. Sesti, V. Trischitta, L. Frittitta
Direct evidence for susceptibility genes for type 2 diabetes on mouse chromosomes 11 and 14
N. Babaya, T. Fujisawa, K. Nojima, M. Itoi-Babaya, K. Yamaji, K. Yamada, M. Kobayashi, H. Ueda, Y. Hiromine, S. Noso, H. Ikegami
A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)γa as a pancreatic beta cell-specific biomarker
D. Flamez, I. Roland, A. Berton, B. Kutlu, D. Dufrane, M. C. Beckers, E. De Waele, I. Rooman, L. Bouwens, A. Clark, M. Lonneux, J. F. Jamar, S. Goldman, D. Maréchal, N. Goodman, P. Gianello, C. Van Huffel, I. Salmon, D. L. Eizirik
In vitro phage display in a rat beta cell line: a simple approach for the generation of a single-chain antibody targeting a novel beta cell-specific epitope
S. Ueberberg, D. Ziegler, W. Schechinger, J. W. Dietrich, S. Akinturk, H. H. Klein, S. Schneider
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes
M. Igoillo-Esteve, L. Marselli, D. A. Cunha, L. Ladrière, F. Ortis, F. A. Grieco, F. Dotta, G. C. Weir, P. Marchetti, D. L. Eizirik, M. Cnop
The role of transmembrane protein 27 (TMEM27) in islet physiology and its potential use as a beta cell mass biomarker
J. Altirriba, R. Gasa, S. Casas, M. J. Ramírez-Bajo, S. Ros, A. Gutierrez-Dalmau, M. C. Ruiz de Villa, A. Barbera, R. Gomis
Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3
E. Law, S. Lu, T. J. Kieffer, G. L. Warnock, Z. Ao, M. Woo, L. Marzban
Beta cell coupling and connexin expression change during the functional maturation of rat pancreatic islets
C. P. F. Carvalho, H. C. L. Barbosa, A. Britan, J. C. R. Santos-Silva, A. C. Boschero, P. Meda, C. B. Collares-Buzato
Deficiency of Atf3, an adaptive-response gene, protects islets and ameliorates inflammation in a syngeneic mouse transplantation model
E. J. Zmuda, M. Viapiano, S. T. Grey, G. Hadley, A. Garcia-Ocaña, T. Hai
IFN-γ and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes
L. G. Petrich de Marquesini, J. Fu, K. J. Connor, A. J. Bishop, N. E. McLintock, C. Pope, F. S. Wong, C. M. Dayan
Toll-like receptors regulate B cell cytokine production in patients with diabetes
M. Jagannathan, M. McDonnell, Y. Liang, H. Hasturk, J. Hetzel, D. Rubin, A. Kantarci, T. E. Van Dyke, L. M. Ganley-Leal, B. S. Nikolajczyk
Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice
Y. Fujita, M. Hosokawa, S. Fujimoto, E. Mukai, A. Abudukadier, A. Obara, M. Ogura, Y. Nakamura, K. Toyoda, K. Nagashima, Y. Seino, N. Inagaki
Hepatocyte nuclear factor (HNF)-4α-driven epigenetic silencing of the human PED gene
P. Ungaro, R. Teperino, P. Mirra, M. Longo, M. Ciccarelli, G. A. Raciti, C. Nigro, C. Miele, P. Formisano, F. Beguinot
Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-γ (PPAR-γ)-deficient mice
S. Z. Duan, M. G. Usher, E. L. Foley IV, D. S. Milstone, F. C. Brosius III, R. M. Mortensen
Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes
N. Karachalias, R. Babaei-Jadidi, N. Rabbani, P. J. Thornalley
Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes
T. K. Hansen, C. Forsblom, M. Saraheimo, L. Thorn, J. Wadén, P. Høyem, J. Østergaard, A. Flyvbjerg, P.-H. Groop
External validation and optimisation of a model for predicting foot ulcers in patients with diabetes
M. Monteiro-Soares, M. Dinis-Ribeiro
Is there a human model for the ‘metabolic syndrome’ with a defined aetiology?
P. Gorden, B. C. Lupsa, A. Y. Chong, A. O. Lungu
Persistence of TNFα in diabetic wounds
R. C. Landis, B. J. Evans, N. Chaturvedi, D. O. Haskard